The production cost of clomipramine is not publicly disclosed by manufacturers. However, as a generic medication, it is generally considered to be a low-cost drug to produce.
How is clomipramine manufactured?
Clomipramine is a tricyclic antidepressant (TCA) synthesized through a multi-step chemical process. The core structure involves dibenzazepine, which is then modified with a specific side chain containing a dimethylamino group. The manufacturing process requires precise control of reaction conditions and purification steps to ensure the final product meets pharmaceutical standards.
What are the active pharmaceutical ingredients (APIs) in clomipramine?
The primary active pharmaceutical ingredient in clomipramine is clomipramine hydrochloride. The synthesis of this API involves several chemical reactions, starting from precursor molecules.
When does the patent for clomipramine expire?
Clomipramine has been available for many decades, and its original patents have long since expired. This means that generic versions of the drug can be manufactured and sold by multiple companies. Information on the patent expiry of specific formulations or manufacturing processes might be available through specialized patent databases.
Who makes generic clomipramine?
Many pharmaceutical companies worldwide produce generic clomipramine. These include both large multinational corporations and smaller regional manufacturers. Availability can vary by country and region.
How does clomipramine compare to other antidepressants?
Clomipramine is a TCA, a class of antidepressants that emerged before selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). While effective, TCAs like clomipramine often have a broader range of side effects compared to newer classes of antidepressants. Clomipramine is particularly known for its potent effects on serotonin reuptake and is sometimes used for conditions like obsessive-compulsive disorder (OCD) where other treatments may be less effective. Newer antidepressants often have a more targeted mechanism of action and a generally more favorable side effect profile.
What are the risks and side effects of clomipramine?
Clomipramine can cause a range of side effects, some of which are more common with TCAs. These include drowsiness, dry mouth, constipation, blurred vision, and urinary retention. More serious side effects can include cardiac arrhythmias, seizures, and a drop in blood pressure upon standing (orthostatic hypotension). Due to these potential risks, clomipramine requires careful monitoring by a healthcare professional.
What is the typical dosage and administration of clomipramine?
Clomipramine is typically administered orally in tablet or capsule form. Dosages are individualized based on the condition being treated and the patient's response. For depression, initial doses are usually lower and gradually increased. For OCD, higher doses may be required. It is crucial to follow a doctor's prescription for dosage and duration of treatment.
What is the clinical data supporting clomipramine's use?
Clinical trials for clomipramine have demonstrated its efficacy in treating depression and, notably, obsessive-compulsive disorder. Its effectiveness in OCD, in particular, has led to its continued use for this indication, often as a first-line or second-line treatment when other options are insufficient.
What are the regulatory approvals for clomipramine?
Clomipramine is approved by regulatory agencies in numerous countries, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), for the treatment of major depressive disorder and obsessive-compulsive disorder.
Sources:
[1] https://www.drugpatentwatch.com/